Recurrent venous thromboembolism during coumarin therapy.: Data from the computerised registry of patients with venous thromboembolism

被引:18
作者
Lobo, Jose Luis [1 ]
Jimenez, David
Orue, Ma Teresa
Grau, Enric
Naufall, Dolores
Madridano, Olga
Monreal, Manuel
机构
[1] Hosp Txagorritxu, Dept Pneumol, Vitoria, Spain
[2] Hosp Univ Ramon & Cajal, Dept Pneumol, Madrid, Spain
[3] Hosp Navarra, Dept Haematol, Pamplona, Spain
[4] Hosp Lluis Alcanyis, Dept Haematol, Xativa, Spain
[5] Hosp Univ La Fe, Dept Pneumol, Valencia, Spain
[6] Hosp Univ La Paz, Dept Internal Med, Madrid, Spain
[7] Hosp Univ German Trias & Pujol, Dept Internal Med, Barcelona, Spain
关键词
anticoagulants; thrombosis (venous); risk factors;
D O I
10.1111/j.1365-2141.2007.06679.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:400 / 403
页数:5
相关论文
共 10 条
[1]   Antithrombotic therapy for venous thromboembolic disease [J].
Büller, HR ;
Agnelli, G ;
Hull, RD ;
Hyers, TA ;
Prins, AH ;
Raskob, GE .
CHEST, 2004, 126 (03) :401S-428S
[2]   Recurrent pulmonary embolism despite inferior vena cava filter placement in patients with the antiphospholipid syndrome [J].
Cherian, J ;
Gertner, E .
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2005, 11 (01) :56-58
[3]   Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy [J].
Douketis, JD ;
Foster, GA ;
Crowther, MA ;
Prins, MH ;
Ginsberg, JS .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (22) :3431-3436
[4]   DIFFERENT INTENSITIES OF ORAL ANTICOAGULANT-THERAPY IN THE TREATMENT OF PROXIMAL-VEIN THROMBOSIS [J].
HULL, R ;
HIRSH, J ;
JAY, R ;
CARTER, C ;
ENGLAND, C ;
GENT, M ;
TURPIE, AGG ;
MCLOUGHLIN, D ;
DODD, P ;
THOMAS, M ;
RASKOB, G ;
OCKELFORD, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (27) :1676-1681
[5]   Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer [J].
Lee, AYY ;
Levine, MN ;
Baker, RI ;
Bowden, C ;
Kakkar, AK ;
Prins, M ;
Rickles, FR ;
Julian, JA ;
Haley, S ;
Kovacs, MJ ;
Gent, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (02) :146-153
[6]   Extended outpatient therapy with low molecular weight heparin for the treatment of recurrent venous thromboembolism despite warfarin therapy [J].
Luk, C ;
Wells, PS ;
Anderson, D ;
Kovacs, MJ .
AMERICAN JOURNAL OF MEDICINE, 2001, 111 (04) :270-273
[7]   Management of patients with acute venous thromboembolism:: Findings from the RIETE registry [J].
Monreal, M ;
Suárez, C ;
Fajardo, JAG ;
Barba, R ;
Uresandi, F ;
Valle, R ;
Rondón, P .
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2003, 33 (5-6) :330-334
[8]   Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis [J].
Prandoni, P ;
Lensing, AWA ;
Piccioli, A ;
Bernardi, E ;
Simioni, P ;
Girolami, B ;
Marchiori, A ;
Sabbion, P ;
Prins, MH ;
Noventa, F ;
Girolami, A .
BLOOD, 2002, 100 (10) :3484-3488
[9]   Predicting adverse outcome in outpatients with acute deep vein thrombosis.: Findings from the RIETE Registry [J].
Trujillo-Santos, Javier ;
Herrera, Salud ;
Page, M. Angeles ;
Soto, M. Jose ;
Raventos, Antoni ;
Sanchez, Rosario ;
Monreal, Manuel .
JOURNAL OF VASCULAR SURGERY, 2006, 44 (04) :789-793
[10]   Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. A retrospective study of 2300 consecutive patients with venous thromboembolism [J].
Veeger, NJGM ;
Piersma-Wichers, M ;
Tijssen, JGP ;
Hillege, HL ;
Meer, J .
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 128 (04) :513-519